Skip to content

Effect of Mass Movement Pattern of trunk in patients with Non-Alcoholic Fatty Liver Disease – A Randomized controlled trail

Effect of Mass Movement Pattern of trunk in patients with Non-Alcoholic Fatty Liver Disease – A Randomized Controlled Trail - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058884
Enrollment
32
Registered
2023-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K759- Inflammatory liver disease, unspecified

Interventions

Intervention1: combining pattern of PNF for trunk: Specific movements of trunk which include: Upper and lower trunk flexion Upper trunk flexion with lower trunk extension Upper and lower trunk extensi

Sponsors

Gouri Kotabagi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. NAFLD diagnosis made by detecting liver steatosis on fibro scan with score of steatoses i.e. controlled attenuation parameter (CAP) = 238 dB/m i.e. 11-33% fatty change in the liver. 2. Patients who are between the ages of 18 to 65 years. 3. Absence of significant alcohol consumption ( 4. Elevated Serum liver enzymes, Lipid profile and plasma glucose and insulin concentrations

Exclusion criteria

Exclusion criteria: 1. The surrogate scores of liver stiffness (LSM) which can be in line with stage 4 fibrosis/cirrhosis = 11 kPa. 2. Uncontrolled diabetes history (HbA1c > 9%) 3. Uncontrolled hypertension 4. Diagnosed cases of disease-preventing administration to aerobic exercise; cardiovascular, neurological, orthopedics disease history. 5. Diagnosed cases of viral hepatitis, autoimmune liver disease, hemochromatosis, or drug-induced hepatotoxicity

Design outcomes

Primary

MeasureTime frame
Fibro scan- Transient elastography will be performed using the Fibro scan according to a standardized protocol Liver function test- Liver function test will be made in an internationally accredited laboratory, using standard methodsTimepoint: 1st- Beginning of intervention 2nd- at the end of 12 weeks of intervention

Secondary

MeasureTime frame
Anthropometric MeasurementsTimepoint: 1st- beginning of intervention 2nd- At the end of 12 weeks of intervention

Countries

India

Contacts

Public ContactGouri Kotabagi

KLE Institute of physiotherapy

sanjiv3303@rediffmail.com9448745648

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026